Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Damae Medical
Paris, Francedamae-medical.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Damae Medical’s deepLive™ device enables non-invasive, real-time 3D imaging of skin at cellular resolution. It has demonstrated clinical utility for early diagnosis of skin cancers and pre-surgical margin definition. The technology has been adopted by dermatologists across Europe and used in clinical research settings in the US. No drug or therapeutic clinical trial results are relevant.
- Therapeutic areas
- OncologyDermatology
- Modalities
- Device (medical imaging)Non-pharmacological therapy
- Industry
- Medical Imaging
02
Partnerships
CNRS (French National Centre for Scientific Research)Institut d’Optique Graduate SchoolUniversité Paris-Sud
Beyond the preview
Go deeper on Damae Medical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Damae Medical.